These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15918330)

  • 1. Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.
    Zheng BJ; Guan Y; Hez ML; Sun H; Du L; Zheng Y; Wong KL; Chen H; Chen Y; Lu L; Tanner JA; Watt RM; Niccolai N; Bernini A; Spiga O; Woo PC; Kung HF; Yuen KY; Huang JD
    Antivir Ther; 2005; 10(3):393-403. PubMed ID: 15918330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.
    Sainz B; Mossel EC; Gallaher WR; Wimley WC; Peters CJ; Wilson RB; Garry RF
    Virus Res; 2006 Sep; 120(1-2):146-55. PubMed ID: 16616792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
    Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
    Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.
    Yuan K; Yi L; Chen J; Qu X; Qing T; Rao X; Jiang P; Hu J; Xiong Z; Nie Y; Shi X; Wang W; Ling C; Yin X; Fan K; Lai L; Ding M; Deng H
    Biochem Biophys Res Commun; 2004 Jul; 319(3):746-52. PubMed ID: 15184046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.
    Liu IJ; Kao CL; Hsieh SC; Wey MT; Kan LS; Wang WK
    Antiviral Res; 2009 Jan; 81(1):82-7. PubMed ID: 18983873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism.
    Guillén J; Pérez-Berná AJ; Moreno MR; Villalaín J
    J Virol; 2005 Feb; 79(3):1743-52. PubMed ID: 15650199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development.
    Choy WY; Lin SG; Chan PK; Tam JS; Lo YM; Chu IM; Tsai SN; Zhong MQ; Fung KP; Waye MM; Tsui SK; Ng KO; Shan ZX; Yang M; Wu YL; Lin ZY; Ngai SM
    Clin Chem; 2004 Jun; 50(6):1036-42. PubMed ID: 15044316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.
    Xu Y; Lou Z; Liu Y; Pang H; Tien P; Gao GF; Rao Z
    J Biol Chem; 2004 Nov; 279(47):49414-9. PubMed ID: 15345712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological, structural, and preliminary X-ray diffraction characterizations of the fusion core of the SARS-coronavirus spike protein.
    Hsu CH; Ko TP; Yu HM; Tang TK; Chen ST; Wang AH
    Biochem Biophys Res Commun; 2004 Nov; 324(2):761-7. PubMed ID: 15474492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.
    Han DP; Penn-Nicholson A; Cho MW
    Virology; 2006 Jun; 350(1):15-25. PubMed ID: 16510163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.
    Zhu J; Xiao G; Xu Y; Yuan F; Zheng C; Liu Y; Yan H; Cole DK; Bell JI; Rao Z; Tien P; Gao GF
    Biochem Biophys Res Commun; 2004 Jun; 319(1):283-8. PubMed ID: 15158473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
    Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
    Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical characterization of HRC peptide analogs interaction with heptad repeat regions of the SARS-coronavirus Spike fusion protein core.
    Yan Z; Tripet B; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):162-75. PubMed ID: 16765058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.
    Kuhn JH; Li W; Radoshitzky SR; Choe H; Farzan M
    Antivir Ther; 2007; 12(4 Pt B):639-50. PubMed ID: 17944271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
    Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
    J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein.
    Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC
    J Virol; 2005 Jun; 79(11):7195-206. PubMed ID: 15890958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides.
    Tarnovitski N; Matthews LJ; Sui J; Gershoni JM; Marasco WA
    J Mol Biol; 2006 May; 359(1):190-201. PubMed ID: 16630634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.